Henrik Carl Schønheyder

Henrik Carl Schønheyder

Auto-generated profile, based on publicly available information

Henrik Carl Schønheyder

Department of Clinical Microbiology, Aalborg University Hospital, 9000 Aalborg, Denmark

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
Karen Marie Thyssen AstvadKaren Marie Thyssen Astvad
Karen Marie Thyssen Astvad
HJH K Johansen
H K Johansen
BRB L Røder
B L Røder
FRF S Rosenvinge
F S Rosenvinge
JKJ D Knudsen
J D Knudsen
Maiken ArendrupMaiken Arendrup
Maiken Arendrup
New data from the years 2012 to 2015 from the Danish National Fungemia Surveillance are reported, and epidemiological trends are investigated in a 12-year perspective (2004 to 2015). During 2012 to 2015, 1,900 of 1,939 (98%) fungal bloodstream isolates were included. The average incidence was 8.4/100,000 inhabitants, and this appears to represent a stabilizing trend after the increase to 10.1/100,000 in 2011. The incidence was higher in males than females (10.0 versus 6.8) and in patients above 50 years, and those changes were mainly driven by an increasing incidence among 80-to-89-year-old males (65.3/100,000 in 2014 to 2015). The proportion ofCandida albicansisolates decreased from 2004 to 2015 (64.4% to 42.4%) in parallel with a doubling of the proportion ofCandida glabrataisolates (16.5% to 34.6%,P< 0.0001).C. glabratawas more common among females (34.0% versus 30.4% in males). Following an increase in 2004 to 2011, the annual drug use stabilized during the last 2 to 3 years of that time period but remained higher than in other Nordic countries. This was particularly true for the fluconazole and itraconazole use in the primary health care sector, which exceeded the combined national levels of use of these compounds in each of the other Nordic countries. Fluconazole susceptibility decreased (68.5%, 65.2%, and 60.6% in 2004 to 2007, 2008 to 2011, and 2012 to 2015, respectively,P< 0.0001), and echinocandin resistance emerged inCandida(0%, 0.6%, and 1.7%, respectively,P< 0.001). Amphotericin B susceptibility remained high (98.7%). Among 16 (2.7%) echinocandin-resistantC. glabrataisolates (2012 to 2015), 13 harbored FKS mutations and 5 (31%) were multidrug resistant. The epidemiological changes and the increased incidence of intrinsic and acquired resistance emphasize the importance of continued surveillance and of strengthened focus on antifungal stewardship.

14 April 2010 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
TCthe International Bacteremia Surveillance Collaborative
the International Bacteremia Surveillance Collaborative
FEFelicity Edwards
Felicity Edwards
HSHenrik C Schønheyder
Henrik C Schønheyder
KKKarina J Kennedy
Karina J Kennedy
OLOuti Lyytikäinen
Outi Lyytikäinen
PCPeter Collignon
Peter Collignon
Salmonella enterica is an important emerging cause of invasive infections worldwide. However, population-based data are limited. The objective of this study was to define the occurrence of S. enterica bacteremia in a large international population and to evaluate temporal and regional differences.

8 January 2015 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
LNLise H Nielsen
Lise H Nielsen
SJSören Jensen-Fangel
Sören Jensen-Fangel
TBThomas Benfield
Thomas Benfield
RSRobert Skov
Robert Skov
BJBente Jespersen
Bente Jespersen
OSOle S. Søgaard
Ole S. Søgaard
Staphylococcus aureus is a leading cause of bloodstream infections among hemodialysis patients and of exit-site infections among peritoneal dialysis patients. However, the risk and prognosis of Staphylococcus aureus bacteremia among end-stage renal disease patients have not been delineated. In this Danish nationwide, population-based cohort study patients with end-stage renal disease and matched population controls were observed from end-stage renal disease diagnosis/sampling until first episode of Staphylococcus aureus bacteremia, death, or end of study period. Staphylococcus aureus positive blood cultures, hospitalization, comorbidity, and case fatality were obtained from nationwide microbiological, clinical, and administrative databases. Incidence rates and risk factors were assessed by regression analysis. The incidence rate of Staphylococcus aureus bacteremia was very high for end-stage renal disease patients (35.7 per 1,000 person-years; 95% CI, 33.8-37.6) compared to population controls (0.5 per 1,000 person-years; 95% CI, 0.5-0.6), yielding a relative risk of 65.1 (95% CI, 59.6-71.2) which fell to 28.6 (95% CI, 23.3-35.3) after adjustment for sex, age, and comorbidity. After stratification for type of renal replacement therapy, we found the highest incidence rate of Staphylococcus aureus bacteremia among hemodialysis patients (46.3 per 1,000 person-years) compared to peritoneal dialysis patients (22.0 per 1,000 person-years) and renal transplant recipients (8.9 per 1,000 person-years). In persons with Staphylococcus aureus bacteremia, ninety-day case fatality was 18.2% (95% CI, 16.2%-20.3%) for end-stage renal disease patients and 33.7% (95% CI, 30.3-37.3) for population controls. Patients with end-stage renal disease, and hemodialysis patients in particular, have greatly increased risk of Staphylococcus aureus bacteremia compared to population controls. Future challenges will be to develop strategies to reduce Staphylococcus aureus bacteremia-related morbidity and death in this high-risk population.

17 October 2012 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
TGthe Danish Staphylococcal Bacteraemia Study Group
the Danish Staphylococcal Bacteraemia Study Group
NMNiels Mejer
Niels Mejer
HWHenrik Westh
Henrik Westh
HSHenrik C Schønheyder
Henrik C Schønheyder
AJAllan G Jensen
Allan G Jensen
TBThomas Benfield
Thomas Benfield
The objective of this study was to assess temporal changes in incidence and short term mortality of Staphylococcus aureus bacteraemia (SAB) from 1995 through 2008.


1 June 2010 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
HSHenrik Carl Schonheyder
Henrik Carl Schonheyder
MSMette Søgaard
Mette Søgaard
Existing data sources for clinical epidemiology: The North Denmark Bacteremia Research Database Henrik C Schønheyder1, Mette Søgaard1,21Department of Clinical Microbiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark; 2Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark Bacteremia is associated with high morbidity and mortality. Improving prevention and treatment requires better knowledge of the disease and its prognosis. However, in order to study the entire spectrum of bacteremia patients, we need valid sources of information, prospective data collection, and complete follow-up. In North Denmark Region, all patients diagnosed with bacteremia have been registered in a population-based database since 1981. The information has been recorded prospectively since 1992 and the main variables are: the patient’s unique civil registration number, date of sampling the first positive blood culture, date of admission, clinical department, date of notification of growth, place of acquisition, focus of infection, microbiological species, antibiogram, and empirical antimicrobial treatment. During the time from 1981 to 2008, information on 22,556 cases of bacteremia has been recoded. The civil registration number makes it possible to link the database to other medical databases and thereby build large cohorts with detailed longitudinal data that include hospital histories since 1977, comorbidity data, and complete follow-up of survival. The database is suited for epidemiological research and, presently, approximately 60 studies have been published. Other Danish departments of clinical microbiology have recently started to record the same information and a population base of 2.3 million will be available for future studies.Keywords: bloodstream infection, epidemiology, register, population-based